ARCHIVES

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

This article is from The Cancer Letter archive.

Vol. 40 No. 09 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Publications: The Cigarette Papers Available On the Web

September 27, 1996

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Nominations Sought For Paul Marks Prizes, Recognizing Discoverise By The Under-45 Set.

April 13, 2001

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998